SNUC is a rare, highly aggressive cancer that arises in the nasal cavity and paranasal sinuses.
INTRODUCTION
Sinonasal undifferentiated carcinoma (SNUC) is a rare, highly aggressive cancer that arises in the nasal cavity and paranasal sinuses. Initially described by Frierson, et al. in 1986 (1) , this tumor is on the spectrum of neuroendocrine sinonasal malignancies, which includes esthesioneuroblastoma, neuroendocrine carcinoma, and small cell carcinoma. There is a male predominance [2-3:1] , and there are no known etiologic factors. SNUC is typically negative for Epstein-Barr virus (2, 3) . In general, SNUC presents as large tumors involving multiple sinonasal structures, often extends into the orbital or cranial cavity and can metastasize to the cervical lymph nodes, lungs, bones, brain, and liver (2, (4) (5) (6) .
The treatment of SNUC includes aggressive multimodal therapy with radiotherapy and chemotherapy and, in some instances, surgery (4, (6) (7) (8) . Despite aggressive management, the prognosis remains poor, and the median survival time from diagnosis is less than 18 months (2, 3).
To better understand the biological features of SNUC and help develop new therapeutic strategies for this disease, establishing a reliable model for laboratory-based analysis is essential.
While other sinonasal malignancy models have been described, these are not relevant to the biological characteristics of SNUC (9, 10) . In this report, we describe the establishment and characterization of the first human SNUC cell line, and present the molecular and phenotypic behavior of this unique system. 
MATERIALS AND METHODS

Primary tumor
A 74-year-old woman was diagnosed and treated at The University of Texas MD Anderson Cancer Center (MDACC) for a T4N0M0 SNUC of the right maxillary sinus. She had received induction chemotherapy with four cycles of etoposide and carboplatin with a partial response prior to undergoing surgical resection of the residual tumor. Under an approved Institutional Review Board protocol, a portion of the resected specimen and matching normal tissue were collected.
Ultrastructural characterization of the SNUC specimen
Transmission electron microscopy was performed by the High Resolution Electron Microscopy Facility at MDACC. A sample was taken from the central portion of the solid tumor from the sinonasal cavity specimen immediately after surgical extirpation, and was preserved in a solution containing 3% glutaraldehyde, 2% formaldehyde, and 0.1 M cacodylate (pH 7.3).
Ultrathin sections were cut with an LKB Ultracut microtome (Leica, Deerfield, IL, USA), stained with uranyl acetate and lead citrate in an LKB Ultrostainer, and examined with a JEM 1010 transmission electron microscope (JEOL, Peabody, MA) at an accelerating voltage of 80 kV. Digital images were obtained using the AMT imaging system (Advanced Microscopy Techniques Corp., Danvers, MA).
Establishing SNUC cell lines from the patient's tumor
Research. The resected specimen was rinsed in phosphate-buffered saline (PBS) containing 500 units of penicillin and 500 µg of streptomycin and was then rinsed in PBS three times. The specimen was minced into 1-to 2-mm 3 pieces and cultured in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen Corporation, Carlsbad, CA) containing 10% fetal bovine serum (FBS) (Sigma-Aldrich, St. Louis, MO), 25 units of penicillin and 25 µg of streptomycin. After 1 month, about 40 tumor colonies were harvested using 3MM Whatman paper soaked with 0.05% trypsin, 0.0076% EDTA 4Na solution in PBS. The colonies were then transferred to 24-well plates and designated as passage 0. Once the passage 0 cells became confluent, they were sequentially replated. Because they were sensitive to regular trypsin-EDTA solution, the cells were treated with TrypLE Express Stable (Invitrogen) when they were expanded. Cells were maintained in 10% FBS DMEM containing 0.1 mg/mL of Primocin (InvivoGen, San Diego, CA).
Two populations originally from independent colonies were designated MDA8788-6 and MDA8788-7 based on their initial colony numbers. Both the MDA8788-6 and MDA8788-7 lines were free from mycoplasma and murine pathogens by the Infectious Microbe PCR Amplification Test (University of Missouri, Research Animal Diagnostic Laboratory, Columbia, MO).
Acquired cell lines and cell culture
Three established human head and neck squamous carcinoma cells lines were used: UMSCC33, OSC19, MDA1386LN, and an established cancer-associated fibroblast cell line. All cell lines were grown on tissue culture dishes in DMEM supplemented with 10% heatinactivated FBS.
STR genotyping
Research. The genomic DNA from the acquired cell lines and from the original fresh frozen tissue were extracted using the Gentra Puregene cell kit (Qiagen, Inc., Valencia, CA) following the manufacturer's instructions. Short tandem repeat (STR) genotyping was performed by the Characterized Cell Line Core Facility at MD Anderson.
Karyotyping
G-banding and spectral karyotyping (SKY) were performed by MD Anderson's Molecular Cytogenetics Facility by using the following procedures:
Chromosome preparation
Exponentially growing cells were exposed to colcemid (0.04 µg/mL) for 25 minutes at 
G-banding
G-banding was performed by treating the slides in trypsin and staining with Giemsa stain using a routine laboratory procedure (11) to characterize the cytogenetic alterations. Slides were analyzed using an Eclipse E400 microscope (Nikon Inc., Melville, NY) and images of metaphases were captured using an Applied Spectral Imaging system equipped with camera and karyotyping software (Vista, CA). A minimum of 15-20 metaphases were karyotyped from each sample.
Spectral karyotyping (SKY)
Research. 
Cell proliferation assay
MDA8788 cells were plated on a 96-well plate at a density of 1-2 x 10 4 /well. After 3, 24, 48, 72, 90, and 120 hours, the culture media were removed; 100 μL of double distilled water was added; and the plates were frozen and thawed three times. A total of 100 μL of Hoechst 33342 solution (20 µM in 10 mM Tris HCl, 2 M NaCl, 1 mM EDTA, pH 7.4) (Invitrogen) was added and measured at 360-nm excitation and 460-nm emission. The proliferation data were analyzed using GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, CA).
Soft agar colony-formation assay
Ten thousand MDA8788 cells were suspended in 0.3% agarose (Lonza Walkersville, Inc., Walkersville, MD) in DMEM containing 20% FBS. This suspension was overlaid onto a solid layer of 0.6% agarose in a six-well plate. The cells were treated with fresh DMEM containing 20% FBS every other day. Three weeks later, the cells were fixed with methanol, stained with 0.02% crystal violet and photographed at x10 magnification.
Anoikis assay
For determination of anoikis resistance, 2 x 10 6 viable MDA8788 cells were cultured as previously described (12) .
Migration and invasion assays
Research. Migration and invasion assays were performed as previously described (13) 
Protein analysis
The cells from all lines (MDA8788-6, MDA8788-7, MDA1368LN, OSC19, UMSCC33
and cancer-associated fibroblasts) were lysed in lysis buffer (50 mM HEPES, 150 mM NaCl, 10 mM EDTA, 10% glycerol, 1% Triton X-100, pH 7. 
Immunohistochemical analysis
Immunohistochemistry was conducted as previously described (14), using Cytokeratin 
Orthotopic skull base model
We used the soft palate model that was established in our group (16) . Briefly, 1 x 10 6 MDA8788-6 cells were suspended in a volume of 15 µL of PBS with 15 µL Matrigel and injected into the muscle of the soft palate. To monitor orthotopic tumor growth in vivo, mice were examined by magnetic resonance imaging (MRI) after 12 days of the injection in the Small Animal Imaging Facility at MDACC. Anesthesia was induced using 5% isoflurane in oxygen, maintained using 1-3% in oxygen, and monitored according to respiratory rate using respiratory bellows and a small animal physiological monitoring system (Small Animal Instruments Inc., Stony Brook, NY, USA). All MRIs were acquired using a 7 T Biospec small animal imaging system (Bruker BioSpin, Rheinstetten, Germany) and imaging gradients with an inside diameter (ID) of 116 mm. A linear volume resonator (72 mm ID) was used for excitation, and a custom electronically tuned and actively decoupled RF surface coil (13 mm ID) was used for signal detection. Scout images to verify animal positioning were followed by high-resolution sagittal 1 mm slices) and T 2 -weighted RARE images (TE/TR 60/3,000 ms, RARE factor 8, 5 averages) of the paramedian dorsal skin.
Images were viewed using ParaVision software (Bruker BioSpin, Rheinstetten, Germany) and ImageJ analysis software (rsb.info.nih.gov/ij/). Measurements were taken after comparison of T 1 and T 2 images to confirm consistency of cutaneous microanatomic strata. All measurements were taken using ParaVision software on representative T 2 -weighted axial slices.
We euthanized mice with carbon dioxide when they became moribund. At the time of death, the full heads of mice were obtained, fixed in formalin solution for 48 hours, decalcified in 5% formic acid for 4 days and paraffin embedded. H&E staining was done on histologic sections of the head to determine the extent of tumor growth and the degree of invasion into surrounding structures.
Statistical Analysis
The unpaired 2-tailed t test was used to compare the differences in mean tumor volume between 2 groups (with or without Matrigel for the tumor injection) with GraphPad Prism 5. P values < 0.05 were considered statistically significant.
Research. The established cell lines grew as adherent and tightly packed monolayers with a polygonal shape and large nuclei ( Figure 1D ). The morphology was maintained across all cell passages.
RESULTS
Histopathologic and genetic characteristics
STR fingerprinting was performed to characterize the isogenic nature of the MDA8788 cell lines to the parent tumor. All DNA extracted from the original specimen and the two new lines had identical short tandem repeats (Supplementary Table) . Comparison to the ATCC STR database and STR data from 49 cell lines in our laboratory revealed that MDA8788 is a unique cell line, distinct from all others in our collection.
Cytogenetic analysis
Cytogenetic analysis of the MDA8788 cells was performed by using G-banding and SKY analysis. G-banding analysis revealed that 12 clonal markers (m1-m12) (Figures 2A and S1) Research. were shared by both cell lines. By combining G-banding and SKY analysis ( Figure 2B ), the following translocations were identified; m1 t (1:17), m2 t (1:22), m3 t (1:15), m4 t (2:12), m5 t (4:15), m6 t (3:6), m7 t (8:19), m8 t (9:10), m9 t (9:16), m10 t (13:13), m11 t (14, 14) and m12 t (18:19) .
Phenotypic behavior of MDA8788 cell lines
We next assessed the replicative behavior of the established cell lines utilizing Hoechst 33342 fluorescence dye. The doubling time of both MDA8788 cell lines was found to be approximately 40 hours, which was slower than a median doubling time of 26.5 hours in head and neck squamous cancer cell lines (10) . To examine the ability of the tumors to grow under anchorage-independent conditions, we performed soft agar assays on both cell lines. Neither cell line formed colonies after 3 weeks, whereas MDA1386LN cells formed large colonies ( Figure   3A ). To test whether the MDA8788 cells are resistant to anoikis (anchorage-dependent programmed cell death), the cells were grown in suspension culture at various time points.
Within 72 hours, most of the MDA8788-6 cells died while the MDA8788-7 cells displayed a 30% viability ( Figure 3B ). These results suggested that, while the SNUC cell lines had behavior characteristics that were reminiscent of squamous cell carcinomas, the lack of growth in soft agar and the relative anoikis sensitivity suggested a more epithelial-like phenotype. To examine the migratory and invasive potential of the SNUC cells, the MDA8788-6 cells were evaluated by in vitro transwell migration and invasion assays. MDA8788-6 did not migrate or invade, even after 48 hours, whereas OSC19 showed both invasion and migration ( Figure S2 ).
Epithelial-mesenchymal transition and neuroendocrine markers in SNUC cells
Research. The MDA8778 cell lines also expressed the epithelial markers E-cadherin and β-catenin, but not the mesenchymal markers N-cadherin, vimentin or α-smooth muscle actin ( Figure 4A ).
The expression pattern of the EMT markers did not change during the course of cell culture ( Figure S3 ). On the other hand, the SNUC tumor was positive for all the markers including the mesenchymal markers ( Figure 4A ). To determine the origin of these mesenchymal markers seen in Western blotting studies, we performed an immunohistochemical analysis of surgical specimen. Examination of H&E stained SNUC specimen revealed areas of epithelial tumor as well as non-tumor components including stroma ( Figure S4A ). The areas of tumor expressed epithelial markers (keratins and E-cadherin, Fig.S4B and S4C, respectively) , but did not express mesenchymal markers. On the other hand, the non-tumor area expressed mesenchymal markers (α-SMA and vimentin, Figures S4D and S4E , respectively) but did not express epithelial markers.
Because SNUC is a neuroendocrine tumor, we also studied the expression level of synaptophysin. 
Tumorigenicity of MDA8788 cells in nude mice
To determine whether the SNUC cell lines were tumorigenic in vivo, viable cells were injected into the flanks of nude mice with or without Matrigel. Both MDA8788-6 and MDA8688-7 cells formed tumors ( Figures 5A and S5A, Figure 6E ), blood vessels ( Figure 6F ) and lymphatic vessels ( Figure 6G ). The in vivo behavior accurately reflected the invasive nature of SNUC tumors in patients.
DISCUSSION
The aim of this study was to establish a reliable and phenotypically-accurate tumor model system for SNUC, and we were successful in establishing and characterizing two novel isogenic SNUC cell lines. Malignant sinonasal tumors are clinically challenging because of their rarity, their proximity to vital structures, and their histologic variety within a complex anatomic region.
These tumors comprise fewer than 3.6% of all malignancies seen in the head and neck (17) .
Among them, SNUC is particularly rare and aggressive. It was first described by Frierson, et al. in 1986 (1), and fewer than 100 cases had been reported by 2005 (18) . Despite multimodality therapy, including surgical resection, chemotherapy and radiotherapy, the prognosis for patients with SNUC is poor; the median survival is less than 18 months (2, 3) and the 5-year survival is less than 20% (19) .
The development and evaluation of new therapeutic approaches for SNUC has been limited by a lack of available models. To better understand and overcome the poor outcomes of patients diagnosed with this disease, establishment of a tumor model of SNUC is essential.
Currently, there are few cell lines derived from sinonasal tumors; most of them were isolated from squamous cell carcinomas (9, 10), and one was established from an intestinal-type sinonasal adenocarcinoma (20) . No stable SNUC cell lines had been reported prior to the development and characterization of the cell lines reported here. These new cell lines are designated MDA8788-6 and MDA8788-7, and they were derived from a T4N0M0 SNUC of the right maxillary sinus of a 74-year-old female who was diagnosed and treated at our center. STR brain and liver (2, (4) (5) (6) . To determine the reliability of our SNUC cell lines in replicating phenotype of SNUCs in patients, the cells were orthotopically implanted to mice. Histological examination showed that developed tumors could invade into the nasal cavity and cranial cavity, indicating that these SNUC cell lines and the orthotopic model may work as powerful preclinical tools.
Immunoblotting assay revealed that MDA8788 cells were positive for pan-keratin, cytokeratin 8, and cytokeratin 19, which are positive in SNUC specimens at high rates (4, 8, (23) (24) (25) (26) . Other epithelial markers and mesenchymal markers were also tested. The SNUC cell lines were also found to express the epithelial markers E-cadherin and β-catenin, but they do not express the mesenchymal markers N-cadherin, vimentin or α-smooth muscle actin, indicating that the SNUC cell lines have epithelial characteristics and not mesenchymal features.
Interestingly, our SNUC specimen expressed the epithelial markers at lower levels than the SNUC cell lines and was positive for the mesenchymal markers. This may be the result of contamination of non-tumor cells, such as cancer-associated fibroblasts. Neither the surgical specimen nor the SNUC cells expressed synaptophysin, despite this tumor's neuroendocrine classification. Some researchers have already reported that SNUCs can often be synaptophysinnegative consistent with our finding (4, 8, 23, 27) .
In summary, this is the first report of establishing stable human-derived SNUC cell lines.
The cell lines are highly tumorigenic and maintain the histologic and molecular features of the original tumor when grown in murine models. Therefore, these lines may serve as useful tools for future studies of SNUC tumor biology, as well as in the development and testing of novel therapies for this deadly disease. The tumors from MDA8788-6 had a similar histopathologic appearance as that of the original surgical specimen (H&E staining; original magnifications x40 (top) and x200 (bottom)). 
